|
SEC11A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.017800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.329440E-01 |
| Normal-vs-Stage2 |
3.973800E-01 |
| Normal-vs-Stage3 |
4.518400E-01 |
| Normal-vs-Stage4 |
4.766400E-01 |
| Stage1-vs-Stage2 |
9.712600E-01 |
| Stage1-vs-Stage3 |
2.758400E-02 |
| Stage1-vs-Stage4 |
3.876400E-02 |
| Stage2-vs-Stage3 |
1.917990E-01 |
| Stage2-vs-Stage4 |
2.032800E-01 |
| Stage3-vs-Stage4 |
9.815000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.797400E-01 |
| Normal-vs-AfricanAmerican |
5.952800E-01 |
| Normal-vs-Asian |
2.832800E-01 |
| Caucasian-vs-AfricanAmerican |
7.491000E-01 |
| Caucasian-vs-Asian |
3.494200E-01 |
| AfricanAmerican-vs-Asian |
7.275200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.514000E-01 |
| Normal-vs-Female |
4.014800E-01 |
| Male-vs-Female |
8.888200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.537780E-01 |
| Normal-vs-Age(41-60Yrs) |
4.789000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.941000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.037800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.207400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.262420E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.785250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.809800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.674600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.672000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.435800E-02 |
| Classical-VS-Follicular |
6.889000E-01 |
| Classical-VS-Other |
2.104600E-01 |
| Classical-VS-Normal |
2.823000E-01 |
| Tall-VS-Follicular |
6.155900E-02 |
| Tall-VS-Other |
3.512000E-02 |
| Tall-VS-Normal |
1.806840E-01 |
| Follicular-VS-Other |
5.243200E-01 |
| Follicular-VS-Normal |
3.216400E-01 |
| Other-VS-Normal |
6.277600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.706000E-01 |
| Normal-vs-N1 |
1.329040E-01 |
| N0-vs-N1 |
1.470400E-02 |
|
|
